ENLV
Price
$1.06
Change
-$0.01 (-0.93%)
Updated
Sep 5 closing price
Capitalization
25.29M
86 days until earnings call
PHRRF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
24.71M
Interact to see
Advertisement

ENLV vs PHRRF

Header iconENLV vs PHRRF Comparison
Open Charts ENLV vs PHRRFBanner chart's image
Enlivex Therapeutics
Price$1.06
Change-$0.01 (-0.93%)
Volume$185.74K
Capitalization25.29M
PharmaTher Holdings
Price$0.27
Change-$0.00 (-0.00%)
Volume$122.72K
Capitalization24.71M
ENLV vs PHRRF Comparison Chart in %
Loading...
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENLV vs. PHRRF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENLV is a Hold and PHRRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ENLV: $1.06 vs. PHRRF: $0.27)
Brand notoriety: ENLV and PHRRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENLV: 27% vs. PHRRF: 18%
Market capitalization -- ENLV: $25.29M vs. PHRRF: $24.71M
ENLV [@Biotechnology] is valued at $25.29M. PHRRF’s [@Biotechnology] market capitalization is $24.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENLV’s FA Score shows that 1 FA rating(s) are green whilePHRRF’s FA Score has 0 green FA rating(s).

  • ENLV’s FA Score: 1 green, 4 red.
  • PHRRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENLV is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENLV’s TA Score shows that 6 TA indicator(s) are bullish while PHRRF’s TA Score has 3 bullish TA indicator(s).

  • ENLV’s TA Score: 6 bullish, 5 bearish.
  • PHRRF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ENLV is a better buy in the short-term than PHRRF.

Price Growth

ENLV (@Biotechnology) experienced а +0.95% price change this week, while PHRRF (@Biotechnology) price change was -3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ENLV is expected to report earnings on Dec 01, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENLV($25.3M) and PHRRF($24.7M) have the same market capitalization . PHRRF YTD gains are higher at: 66.461 vs. ENLV (-9.402). ENLV has more cash in the bank: 20.6M vs. PHRRF (1.55M).
ENLVPHRRFENLV / PHRRF
Capitalization25.3M24.7M102%
EBITDA-14.04MN/A-
Gain YTD-9.40266.461-14%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash20.6M1.55M1,326%
Total Debt503KN/A-
FUNDAMENTALS RATINGS
ENLV: Fundamental Ratings
ENLV
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENLVPHRRF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 16 days ago
88%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IHICY25.882.18
+9.18%
IHI Corp
STLJF57.541.46
+2.60%
Stella Jones Inc.
KMRPF4.33N/A
N/A
Kenmare Resources Ltd.
MYNDF0.03N/A
N/A
MYND Life Sciences Inc.
LCGMF0.09N/A
-0.49%
LION COPPER & GOLD CORP.

ENLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-0.93%
APVO - ENLV
36%
Loosely correlated
-1.23%
FENC - ENLV
26%
Poorly correlated
-1.96%
OCUL - ENLV
26%
Poorly correlated
+7.09%
JANX - ENLV
24%
Poorly correlated
+0.17%
KZIA - ENLV
24%
Poorly correlated
-4.08%
More

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
-0.07%
HOTH - PHRRF
22%
Poorly correlated
-0.75%
OTLK - PHRRF
20%
Poorly correlated
+5.27%
SEOVF - PHRRF
20%
Poorly correlated
+3.89%
ENLV - PHRRF
20%
Poorly correlated
-0.93%
CELZ - PHRRF
14%
Poorly correlated
+0.61%
More